Drug intelligence / Profile preview

procaine merethoxylline

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous
01

Overview

**Procaine merethoxylline** is an organomercury small-molecule salt comprising the mercurial diuretic merethoxylline and procaine. It was historically used as a component of **Dicurin Procaine**, an injectable product that also contained theophylline, for treatment of edema and ascites. The mercurial component promotes diuresis through inhibition of renal sodium ion absorption, while procaine was included to reduce local irritation associated with injection of the mercury-containing compound. The substance is a previously marketed U.S. drug and is not a currently developed modern therapeutic program. ([drugs.ncats.io](https://drugs.ncats.io/substance/O77D636VYN))

Other names
60064-28-0[3-[[2-(carboxymethoxy)benzoyl]amino]-2-(2-methoxyethoxy)propyl]mercury (1+);2-(diethylamino)ethyl 4-aminobenzoate;hydroxideMerethoxyline procaineMerethoxylline procaineO77D636VYNO-77D636VYNO 77D636VYN
02

Targets

Nicotinic Acetylcholine ReceptorADRB1 (β1)NaV alpha (Voltage-gated sodium channel alpha subunit family)NMDAR (Glutamate receptor ionotropic, NMDA)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on procaine merethoxylline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on procaine merethoxylline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call